DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
about
Animal models for Ebola and Marburg virus infectionsCurrent ebola vaccinesMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesEnvironmental health research in the post-genome era: new fields, new challenges, and new opportunitiesEbolavirus vaccines for humans and apesEbola virus vaccines: an overview of current approachesMouse models for filovirus infectionsGlobal research trends of World Health Organization's top eight emerging pathogens.Progress of vaccine and drug development for Ebola preparednessEbola hemorrhagic Fever and the current state of vaccine developmentEbola and Marburg virus vaccines.Ebola virus can be effectively neutralized by antibody produced in natural human infection.Immunological properties of gene vaccines delivered by different routes.Ebola Vaccine: How Far are we?Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.Infectivity-enhancing antibodies to Ebola virus glycoprotein.Ebola virus VP40-induced particle formation and association with the lipid bilayer.Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoproteinEbola virus pathogenesis: implications for vaccines and therapies.Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteinsReverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.DNA vaccines for biodefense.Ebola virus-like particles protect from lethal Ebola virus infection.The multiple roles of sGP in Ebola pathogenesisTackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccinesParticle-mediated DNA vaccine delivery to the skin.Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms.The evolving field of biodefence: therapeutic developments and diagnostics.Filovirus-like particles as vaccines and discovery tools.Epidermal delivery of protein and DNA vaccines.Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.Persistent infection with ebola virus under conditions of partial immunity.Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.DNA immunization.
P2860
Q21131118-700FD9AA-3EF4-4C7F-8FC0-9B45D6F54D71Q21534720-A3BBC9C7-CE59-4572-999E-50851BF29555Q21562420-67D1AB7C-EC48-4559-9FEA-37EB2A824AC8Q23914178-9737E273-522F-4D90-AB4D-86E2EF57FA60Q24631696-3C9AB93E-AD91-44C8-85FD-43D6933C3443Q26999232-440025BA-03BB-4C42-8CE5-200CD8969E13Q27011569-935405EB-3C6C-4861-9EE6-6C8419FDA112Q30151375-F09AFE56-C686-47B5-A51B-C164E7987B59Q30204870-6F418FA0-CCC8-4AC6-BE54-1035AEBA8DDAQ30205198-95E1DA75-162E-4328-BB21-0FD27B304160Q30234637-AA055A07-8537-4E42-80DF-97A72818B6B1Q30712477-A75734F4-3600-47E6-96F5-09352455662AQ33646664-8652065F-168A-45A7-8DD6-14E747A36444Q33831877-FE9E3DD9-AF1A-4D87-A93F-30BDD71ECB85Q33840716-9952BD20-89B9-42DE-B042-B6C0115CD938Q33850032-700C5849-2AF7-433D-ABE1-3EE041347C81Q33850720-94CEAE78-01A8-46DE-BE4C-4BBF2D6B0106Q33851872-CF76C6CA-EB87-4674-ADE1-E847A16689C1Q33865376-1E5B1309-CBB4-4571-AA7F-3EBCD9C4112AQ33967985-5EBBB7A8-EDCF-4D07-BCFA-34D506A5C9FDQ34007162-925FB83D-8B3B-40C8-B9C3-D506FA6B735BQ34123838-46FF5072-6E27-48B8-8D0D-135C5ABCD9C6Q34326549-BA147BCE-0253-4B41-8D31-B02EDDCBF16CQ34345308-2497F165-9B2D-4428-81C4-F649457D1B23Q34583832-A9423F9C-6D2B-4015-ABE9-C878FFACA36FQ34614260-14225D00-D645-450D-8828-62D227C9E034Q34792924-F7CBF255-3162-47F8-A60B-1A9A4C77DDB1Q34869463-8EEE3780-809C-41AD-9DF3-A099841183E9Q34971349-923CF4D0-BFD9-4A68-B32D-E088E9C01C07Q35635459-8DCA6737-D223-4032-96BD-1632637D7148Q35790864-CB553FC5-93FE-424E-BC91-AD24BD90C829Q35955731-B44E1AFE-86C6-43C6-B8DB-25210BDB0178Q36085668-FF2A127F-69AB-4964-BBC8-8F83AB07E893Q36198685-368E2347-4203-407F-AD6E-84DEA1F92954Q36316708-2B1B3C2F-37E2-4EB5-AE6C-66C9F7C67F6EQ36370336-9BB7713F-C559-437C-8BAD-B262ACF7C03EQ36942635-7D9A3AA9-018F-4AD7-BCB2-53781727F2B0Q36943931-D4DE2C61-10BD-4163-9A75-DC649C758868Q36995725-D01ACA70-A291-4A18-8121-8299440CB5A0Q37576264-F5AB5F4E-D237-4C4B-8FE3-08239737E1EC
P2860
DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
DNA vaccines expressing either ...... ct mice from lethal challenge.
@en
DNA vaccines expressing either ...... ct mice from lethal challenge.
@nl
type
label
DNA vaccines expressing either ...... ct mice from lethal challenge.
@en
DNA vaccines expressing either ...... ct mice from lethal challenge.
@nl
prefLabel
DNA vaccines expressing either ...... ct mice from lethal challenge.
@en
DNA vaccines expressing either ...... ct mice from lethal challenge.
@nl
P2093
P356
P1433
P1476
DNA vaccines expressing either ...... ct mice from lethal challenge.
@en
P2093
Jahrling P
Schmaljohn A
Schmaljohn C
Vanderzanden L
P304
P356
10.1006/VIRO.1998.9176
P407
P577
1998-06-01T00:00:00Z